MHRA Drug Safety Update February 2022
Links to the MHRA Drug Safety Update for February 2022 are listed below.
- COVID-19 antivirals: reporting to the UK COVID-19 Antivirals Pregnancy Registry
- Hydroxychloroquine, chloroquine: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions
- Ivacaftor, tezacaftor, elexacaftor (Kaftrio▼) in combination with ivacaftor (Kalydeco): risk of serious liver injury; updated advice on liver function testing
- COVID-19 vaccines and medicines: updates for February 2022
You can sign up to receive these alerts directly from the MHRA at: MHRA email alerts
Published 14/03/2022. Medicines Update blogs are correct at the time of publication.
We would like to hear what you think of Medicines Update blogs. Please leave us your feedback using this anonymous survey here.